Effects of low-molecular-weight and unfractionated heparin on trophoblast function

Obstetrics and Gynecology

Volumn 104, Issue 2, 2004, Pages 354-361

  Quenby, Siobhan ^a   Mountfield, Steve ^b   Cartwright, Judith E ^b   Whitley, Guy St J ^b   Vince, Gill ^b  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; SCATTER FACTOR; ANTICOAGULANT AGENT;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MOTILITY; CHORION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GIANT CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROSCOPY; MULTINUCLEAR CELL; PLACENTA; PRIORITY JOURNAL; TROPHOBLAST; CELL LINE; CELL MOTION; DOSE RESPONSE; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; THROMBOPHILIA;

ANTICOAGULANTS; ASPIRIN; CELL LINE; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA; TROPHOBLASTS;

EID: 4344662671     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000128902.84876.d4     Document Type: Article

References (39)

1. Kutteh WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-9.
2. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997;314:253-7.
3. Lewis G, Drife J. Why mothers die 1997-1999. London (UK): RCOG Press; 2001.
4. Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-8.
5. Preston FE, Rosendaal FR, Walker ID, Briet E, Berntorp E, Conard J, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913-6.
6. Kupferminc M, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
7. Kupferminc M, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy [published erratum appears in N Engl J Med 1999;341:384]. N Engl J Med 1999;340:9-13.
8. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 2003;361: 901-8.
9. Mousa HA, Alfirevic Z. Do placental lesions reflect thrombophilia state in women with adverse pregnancy outcome? Hum Reprod 2000;15:1830-3.
10. Salafia CM, Cowchock FS. Placental pathology and antiphospholipid syndrome: a descriptive study. Am J Perinatol 1997;14:435-41.
11. Salafia CM, Parke AL. Placental pathology in systemic lupus erythematosus and phospholipid antibody-syndrome [review]. Clin Rheum Dis 1997;23:85-97.
12. Sebire NJ, Fox H, Backos M, Rai R, Paterson C, Regan L. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002;17:1067-71.
13. Sebire NJ, Backos M, El Gaddal S, Goldin RD, Regan L. Placental pathology antiphospholipid antibodies and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003;101:258-63.
14. Rote NS, Chang J, Katsruagawa H, Ng AK, Lyden TW, Mori T. Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells. Am J Reprod Immunol 1995;33:14-21.
15. Rote NS, Vogt E, DeVere G, Obringer AR, Ng AK. The role of placental trophoblast in the pathophysiology of the antiphospholipid syndrome [review]. Am J Reprod Immunol 1998;39:125-6
16. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997;56:50-8.
17. Chamley LW, Duncalf AM, Mitchell MD, Johnson PM. Action of anticardiolipin and antibodies to beta2-glycoprotein-1 on trophoblast proliferation as a mechanism for fetal death. Lancet 1998;352:1037-8.
18. Di Simone N, Ferrazzani S, Castellani R, De Carolis S, Mancuso S, Caruso A. Heparin and low-dose aspirin restore placental human chorionic gonadotrophin secretion abolished by antiphospholipid antibody-containing sera. Hum Reprod 1997;12:2061-5.
19. Di Simone N, Caliandro D, Castellani R, Ferrazzani S, De Carolis S, Caruso A. Low-molecular weight heparin restore in-vitro trophoblast invasiveness and differentiation in presences of immunoglobulin G fractions obtained from patients with antiphospholipid syndrome. Hum Reprod 1999;14:489-95.
20. di Somone N, Meroni PL, de Papa N, Raschi E, Caliandro D, De Carolis CS, et al. Antiphospholipid antibodies affect trophoblast gonadotrophin secretion through adhered β2-glycoprotein 1. Arthritis Rheum 2000;43:140-50.
21. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a controlled treatment trial [published erratum appears in Obstet Gynecol 2002;100:1361]. Obstet Gynecol 2002;100:408-13.
22. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a controlled treatment trial [published erratum appears in Obstet Gynecol 2002;100:1361]. Obstet Gynecol 2002;100:408-13.
23. Empson M, Lassere M, Craig JC, Scott JR. Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials [review]. Obstet Gynecol 2002;99:135-44.
24. Rai R, Backos M, Baxter N, Chilcott I, Regan L. Recurrent miscarriage: an aspirin a day? Hum Reprod 2002;15:2220-3.
25. Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review [review]. BMJ 2001;322:329-33.
26. Coomarasamy A, Honest H, Papaioannou S, Gee H, Khan KS. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review [review]. Obstet Gynecol 2003;101:1319-32.
27. Shorter SC, Jackson MC, Sargent IL, Redman CW, Starkey PM. Purification of human cytotrophoblast from term amniochorion by flow cytometry. Placenta 1990;11:505-13.
28. Shiverick KT, King A, Frank H, Whitley GS, Cartwright JE, Schneider H. Cell culture models of human trophoblast II: trophoblast cell lines - a workshop report. Placenta 2001;22(suppl):S104-6.
29. Cartwright JE, Holden DP, Whitley GS. Hepatocyte growth factor regulates human trophoblast motility and invasion in a nitric oxide dependent manner. Br J Pharmacol 1999;128:181-9.
30. Barbour LA, Smith JM, Marlar RA. Heparin levels to guide thromboembolism prophylaxis during pregnancy. Am J Obstet Gynecol 1995;173:1869-73.
31. Dekker GA, Sibai BM. Low-dose aspirin in the prevention of pre-eclampsia and fetal growth retardation: rationale, mechanisms and clinical trials. Am J Obstet Gynecol 1993; 168:214-27.
32. Cartwright JE, Tse WK, Whitley GS. Hepatocyte growth factor induced human trophoblast motility requires phosphatidylinositol 3-kinase, mitogen activated protein kinase and inducible nitric oxide synthase. Exp Cell Res 2002; 279:219-26.
33. Hansen JB, Sandset PM. Differential effects of low molecular weight heparin and unfractionated heparin on circulating levels of antithrombin and tissue factor pathway inhibitor (TFPI): a possible mechanism for difference in therapeutic efficacy. Thromb Res 1998;1:177-81.
34. Bendz B, Hansen JB, Andersen TO, Ostergaard P, Sandset PM. Partial depletion of tissue factor pathway inhibitor during subcutaneous administration of unfractionated heparin, but not with two low molecular weight heparins. Br J Haematol 1999;107:756-62.
35. Nelson-Piercy C, Letsky EA, De Swiet M. Low-molecular-weight heparin for obstetric thrombophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997;176:1062-8.
36. Chobotova K, Spyropoulou I, Carver J, Manek S, Heath JK, Gullick WJ, et al. Heparin-binding epidermal growth factor and its receptor ErbB4 mediate implantation of the human blastocyst. Mech Dev 2002;119:137-44.
37. Leach RE, Romero R, Kim YM, Chaiworapongsa T, Kilburn B, Das SK, et al. Pre-eclampsia and expression of heparin-binding EGF-like growth factor. Lancet 2002;360:1215-9.
38. Lash GE, Cartwright JE, Whitley GS, Trew AJ, Baker PN. The effects of angiogenic growth factors on extravillous trophoblast invasion and motility. Placenta 1999;20:661-7.
39. Mamluk R, Gechtman Z, Kutcher ME, Gasiunas N, Gallagher J, Klagsbrun M. Neuropilin-1 binds vascular endothelial growth factor 165, placental growth factor-2 and heparin via its b1b2 domain. J Biol Chem 2002;277:24818-25.